Development of Cellular Therapeutics

Prof. Wolfgang Holter, MD
Our group focuses on the development of therapeutic strategies based on T cells modified with chimeric antigen receptors (CARs).

Tumour Immunology

Alexander Dohnal, PhD
The last decades brought enormous progress in our understanding of the cellular and molecular biology of cancerous disease. One of the areas of hope is cancer immune therapy. We work on concepts for manipulating the immune system in order to trigger anti-tumour immunity, which has the capacity to control the growth of cancer cells.  

Clinical Cell Biology and FACS Core Unit

Assoc. Prof. Gerhard Fritsch, PhD
With our engagement in flow cytometry and GMP-compliant work, we are a supportive interface between research and therapy.